Do you plan to point out what is illogical or “crazy” about this post? Unlikely. More likely, there isn’t anything illogical about what I posted and you are totally fine with a shortened life span and addiction to passive solutions because life is hard. |
I wear shoes when I run. Nothing "natural" about that. |
There is nothing valuable about suffering. |
You are going to have to explain how this post demonstrates victim mentality? |
PP didn't want to grapple with the ways in which human inventions have helped people deal with health conditions. Because they want people to grapple with this specific health condition "naturally" because of reasons. |
Please keep posting, crazy!! You are entertaining. I don’t take Ozempic, I don’t have a weight problem, and I don’t drink because I don’t like it. My family tends to live well into their late 90s. You know being totally insane and miserable can harm your life? Your misery and scrabbling fear that someone, somewhere has had an easier life than you think they deserve is harming you, you know. Take a breath and let it all go. |
Still waiting to read what was crazy or illogical. |
Not “easier,” possible. And once again you are assuming that anyone who is obese is mentally ill. Then you go on to assume that anyone who loses weight with drugs or surgery or whatever hasn’t put in the work of eating better, exercising and dealing with emotional issues. That’s completely arrogant. |
Europe is investigating 150 cases, not 3. https://www.ema.europa.eu/en/news/ema-statement-ongoing-review-glp-1-receptor-agonists |
“The review of Ozempic, Saxenda and Wegovy started on 3 July 2023 and has now been extended to include other GLP-1 receptor agonists. This review is expected to conclude in November 2023.” So if my research is correct, exenatide (Byetta), liraglutide (Saxenda), lixisenatide (Lyxumia in the EU, Adlyxin in the US), dulaglutide (Trulicity), and semaglutide (Ozempic/Wegovy). That’s a few more drugs than just semaglutide, and since it’s gone from 3 cases to 150 in the expansion of the study, it would suggest that it’s one of these other GLP-1 agonists that is causing a problem or perhaps causes a problem when used in tandem with another drug. |
God forbid you introduce facts. The anti-Wegovy posters would lose their minds. |
I'm not going to read all the back and forth arguing, so apologies if someone has already said this. But it's honestly not surprising that GLP-1 agonists could have this effect on some people. There are lots of GLP-1 receptors in the brain and they have been implicated in reward processing. This is probably why GLP-1 agonists are more effective than other weight loss drugs. These agonists reduce craving/wanting and rumination about food. Some people taking it have lamented that they don't enjoy certain food/drink the way they used to. It stands to reason that GLP-1 receptors could trigger an anhedonia of sorts in some people for reasons we don't yet understand. As more studies are done we will find out more about the effects of these drugs on brain circuits important for reward, emotion, and mood regulation.
|
GLP-1 agonists, not receptors |
Thank you. |
I’m the op you’re replying to and I’m glad Europe is checking it out if it’s legit come to their attention, but Ozempic has been available since 2017. It’s not a new-new drug untested by anyone. You can hear people all but smacking their lips in excitement at this news of possible mental health side effects. These people, for all they have posted on here for years about how they don’t want to shame anyone for being fat, they’re just concerned about how unhealthy fat is. Now that people have a real tool for weight loss, they’re very concerned about that, too. |